期刊文献+

基准剂量法在长期暴露毒性评价中的研究进展 被引量:5

Research progress in benchmark dose in risk assessment of long-team exposure toxicity
原文传递
导出
摘要 风险评估是为了评价特定危害因素下的人群暴露水平。传统毒性分析方法常采用未观察到有害作用剂量(NOAEL)对毒性结果进行定量,除以不确定系数,以外推得到人群的安全摄入水平(ADI)和参考剂量(Rf D)。多年实践证明,NOAEL法过多依赖实验设计,在安全性评价应用中存在诸多局限性。基准剂量(BMD)法是一种新的确定Rf D的方法,具有诸多优点,能更科学地进行风险评估。该文综述了BMD法原理及分析软件、与NOAEL相比的优点、在长期暴露毒性实验中应用及方法完善等的研究进展,为后期在长期暴露毒性实验及其他化合物风险评估中的应用提供相关参考。 The purpose of risk assessment is to evaluate the permissible exposure level under specific risk factors. To extrapolate the human acceptable daily intake( ADI) and / or reference dose( Rf D),the traditional method uses the noobserved-adverse-effect level( NOAEL) to quantify toxicity after being divided by uncertainty factor. There are many limitations with NOAEL method in safety evaluation,for it relies too much on experimental design. Benchmark dose( BMD)approach is a more reliable method with many advantages. BMD approach and its analysis software,the advantages of BMD over NOAEL,the application and methodological perfection in risk assessment of long-team exposure toxicity are presented in this review.
出处 《军事医学》 CAS CSCD 北大核心 2016年第10期851-855,共5页 Military Medical Sciences
基金 国家自然科学基金重点资助项目(81430090)
关键词 基准剂量 未观察到有害作用剂量 风险评估 长期暴露毒性 benchmark dose no-observed-adverse-effect level risk assessment long-term exposure toxicity
  • 相关文献

参考文献28

  • 1Crump KS. A new method for determining allowable daily intakes [Jl. Fundam Appl Toxicol, 1984, 4(5) : 854 -871.
  • 2Barnes DG, Daston GP, Evans JS, et al. Benchmark Dose Workshop: criteria for use of a benchmark dose to estimate a reference dose [J]. Regul Toxicol Pharmacol, 1995, 21(2): 296 - 306.
  • 3金泰廪,雷立健,常秀丽,等.基准剂量法-制定生物接触阈限值的新方法[A].预防医学学科发展蓝皮书(2006卷).2006:15-20.
  • 4方瑾,贾旭东.基准剂量法及其在风险评估中的应用[J].中国食品卫生杂志,2011,23(1):50-53. 被引量:11
  • 5Kavlock RJ. Recent advances in mathematical modeling of devel- opmental abnormalities using mechanistic information [ J ]. Reprod Toxicol, 1997, 11(2 -3) : 423 -434.
  • 6Zhu Y, Wessel MR, Liu T, et al. Analyses of neurobehavioral screening data: dose-time-response modeling of continuous outcomes [J]. Regul Toxicol Pharmacol, 2005, 41 (3): 240- 255.
  • 7Darmer KI Jr. , Haun CC, MaeEwen JD. The acute inhalation toxicology of chlorine pentafluoride [ J ]. Am Ind Hyg Assoc J, 1972, 33(10) : 661 -668.
  • 8Crump K. Critical issues in benchmark calculations from continuous data [J]. Crit Rev Toxicol, 2002, 32(3) : 133 -153.
  • 9Foster PM, Auton TR. Application of benchmark dose risk assessment methodology to developmental toxicity: an industrial view [J]. Toxicol Lett, 1995, 82-83:555-559.
  • 10OECD. OECD Guidelines for the Testing of Chemicals, 452 Chronic Toxicity Studies, 1-16 [A]. Paris: OECD, Adopted 7 September, 2009.

二级参考文献89

  • 1田琳,路小婷,金泰廙.基准剂量在危险度评价中的应用及发展[J].中华劳动卫生职业病杂志,2004,22(4):290-292. 被引量:7
  • 2李颖,薛寿征.化学物致畸作用阈值判断──兼论烯效唑的致畸测试结果与ADI的拟订[J].癌变.畸变.突变,1996,8(1):14-17. 被引量:6
  • 3姬海莲.铝电解厂周围地区人群氟斑牙和尿氟水平调查[J].环境与健康杂志,2006,23(6):520-521. 被引量:8
  • 4WS/T113-1999,中华人民共和国卫生行业标准生物监测指标和职业接触生物限值.
  • 5Buchet JP,Lauwerys R,Roels H .Renal effects of cadmium body burden of the general population.Lancet ii,1990,336:699-702.
  • 6Nordberg GF.Current issues in low-dose cadmium toxicology:nephrotoxicity and carxinogenicity.Environ Sci,1996,4:133-147.
  • 7Kimmel CA,Gaylor DW.Issues in qualitative and quantitative risk analysis for developmental toxicity.Risk Anal,1988,8:15-20.
  • 8Gaylor D,Ryan L,Krewski D,et al.Procedures for calculation benchmark doses for health risk assessment.Regul Toxicol Pharmarcol,1998,28,150-164.
  • 9WHO.Cadmium Environmental Aspects:Environmental Health Criteria 135.WHO,Geneva,1992.
  • 10Crump KS.A new method for determining allowable daily intakes.Fundam Appl Toxicol,1984,4:854-871.

共引文献36

同被引文献51

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部